ABBV has been in the news 375% more than usual
Nov 02, 2025, 2:31 AM
4.43%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie Inc's short interest increased by 10.87% to 18.08 million shares, representing 1.02% of its float, with a coverage time of 2.61 days. This information reflects market activity but does not indicate AbbVie's earnings or stock performance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.